GSE182680 GSE182683 dexamethasone 5 v 11 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182680_GSE182683_dexamethasone_5_v_11_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182680_GSE182683_dexamethasone_5_v_11_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182680_GSE182683_dexamethasone_5_v_11_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182680_GSE182683_dexamethasone_5_v_11_human_up.

Results found

Linked to

 

Label

Description

 

Gene

synergin gamma

Gene

A-kinase anchoring protein 17A

Gene

cytoskeleton regulator RNA

Gene

PAX8 antisense RNA 1

Gene

long intergenic non-protein coding RNA 665

Gene

RNA polymerase II subunit J3

Gene

HERC2 pseudogene 2

Gene

protein kinase Y-linked (pseudogene)

Gene

long intergenic non-protein coding RNA 3040

Gene

long intergenic non-protein coding RNA 3219


  • Gene

    A-kinase anchoring protein 17A


  • Gene

    cytoskeleton regulator RNA


  • Gene

    PAX8 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    RNA polymerase II subunit J3


  • Gene

    HERC2 pseudogene 2


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    long intergenic non-protein coding RNA 3219

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.